How to treat mycoplasma chlamydia infection

For the treatment of mycoplasma chlamydia infection, the preferred drug is macrolide antibacterial drugs, such as erythromycin, roxithromycin and azithromycin, which are commonly used in clinical practice. After mycoplasma or chlamydia infection, antimycoplasma or antichlamydia therapy is best recommended if there are clinical symptoms. Antibiotics that are more sensitive to mycoplasma or chlamydia infection are generally macrolides, such as erythromycin, azithromycin, roxithromycin, etc., with a better treatment effect, and the course of treatment is generally 2~3 weeks, and the course of anti-mycoplasma or chlamydia infection should be determined according to the severity and age of the child's condition.Because Mycoplasma pneumoniae is the smallest extracellular microorganism and a class of prokaryotic cell-type microorganisms lacking a cell wall, antimicrobial drugs such as penicillins or cephalosporins that mainly inhibit the synthesis of bacterial cell walls and cause cell rupture and death are ineffective. If it is confirmed that secondary bacterial infection is present, targeted antimicrobial treatment can be selected according to the sputum etiological examination. Mycoplasma and chlamydia infections are prone to recurrence, so in the process of anti-mycoplasma or chlamydia, it is necessary to ensure an adequate course of treatment and a sufficiently effective dose.